Cancer is the leading cause of death in the US today, with breast, prostate, lung and colonic cancers being the most prevalent. Well-established conventional modalities focusing on systemic control (such as chemo therapy) or on local treatment (such as surgery and radiation) have so far offered only limited success. Instead, new research has shown that the optimal cancer treatment modality is one that restores and stimulates the normal immunobiological responses against an undesirable growth.

Immunophotonics Inc is a US-based research-oriented company in the frontline of immunotherapy research. Our main objective is to develop and introduce Laser-Assisted Immunotherapy, one of the most innovative and promising modalities for metastatic tumors to have emerged in the world of cancer research.